Center for Translational Research AB (CTR) expands by acquiring Zelmic AB, the GMP-approved Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), specialized in development of topical and transdermal pharmaceutical formulations and drug delivery. The acquisition further expands CTRs portfolio, within pharmaceutical, regulatory, and clinical development to the CTR group.
Read moreMeet us at NLSDays in Copenhagen!
Read moreSeptember 7th at the Medicon Village in Lund Zelmic will participate at The Future of Swedish & Danish Life Scence held at Medicon Village (Restaurant & Café Inspira). See you there!
Read moreSeptember 6th in Copenhagen Zelmic will participate at the event New Updates in Drug Formulation & Bioavailabilityheld at Medicon Valley Alliance headquarters in Copenhagen on September 6th 2023. See you there!
Read moreHighlighting the latest trends, accomplishments, and innovations in the field of topical development for Zelmic:
Read moreWelcome to our Open house at Zelmic
Read moreAs we move into the new year, I wanted to take a moment to update you on the exciting developments happening at our organization.
Read moreZelmic will participate at CPHI Frankfurt on November 1-3, 2022 David Sagna is excited to meet new clients and suppliers to discuss topical drug development and the opportunities with the new IMP topical manufacturing unit. This trip was facilitated in connection with the EU.
Read moreJoin us at NLSdays for CMC discussions.
Read moreMeet us in Copenhagen 6th of September
http://www.formulationsbioavailability.com/
Read more